|
Clopidogrel Clinical Trials
9 actively recruiting trials across 2 locations
▲ +2 trials since June 2026
Also known as: Clopidogrel Hydrogen Sulphate Tablets, Platless Tab., Plavix
Pipeline
Phase 1: 1Phase 2: 1Phase 3: 2Phase 4: 5
Top Sponsors
- University of Florida2
- St. Antonius Hospital1
- Shanghai CureGene Pharmaceutical Co., Ltd.1
- Seoul National University Bundang Hospital1
- Peking Union Medical College Hospital1
Indications
- Heart Disease8
- Coronary Artery Disease3
- Percutaneous Coronary Intervention2
- Acute Coronary Syndrome2
- Recent Stroke1
Other6 trials
Jacksonville, Florida2 trials
Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
University of Florida Health
Phase 4
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
University of Florida Jacksonville
Phase 4
Miami, Florida1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.